Ionis Pharmaceuticals Stock Forecast
NASDAQ: IONSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
After hours: 43.30 0.00%
IONS analyst consensus
Consensus (23 analysts)
buy
Avg. price target
$83.64+93.16%
- Strong buy 9
- Buy 9
- Hold 5
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 23 Wall Street analysts covering Ionis Pharmaceuticals (2026-10-08), 18 rate the stock a buy or strong buy, 5 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "buy". The average 12-month price target is $83.64, with a high estimate of $105.00 and a low estimate of $54.00. The average target implies upside of 93.2% from the current price of $43.30.
The spread between the highest and lowest targets is 94.4%, a wide range that reflects significant disagreement among analysts. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for IONS.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 9 | 39% |
| Buy | 9 | 39% |
| Hold | 5 | 22% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-08.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $54.00 | +24.71% |
| Average target | $83.64 | +93.16% |
| High target | $105.00 | +142.49% |